ARXX Therapeutics ApS — Credit Rating and Financial Key Figures

CVR number: 40868151
Hørkær 12 A, 2730 Herlev

Income statement (kDKK)

2020
2021
2022
2023
Fiscal period length12121212
Net sales2 129.482 396.655 789.922 790.58
Costs of manufacturing-7.91-2 635.78- 427.78
External services- 464.42-13.65- 191.19- 208.51
Gross profit1 665.061 654.352 223.101 877.76
Costs of management- 720.74- 739.85- 276.53
Wages and salaries-1 594.64-1 621.42-1 631.06-1 456.38
Social security expenses-12.03- 136.90- 185.28
Other operating expenses-58.39
EBIT32.94455.14236.09
Other financial income49.28205.6953.00
Other financial expenses-3.34-4.86-9.97-13.60
Pre-tax profit-3.3477.35650.86275.49
Income taxes- 143.75-5.73
Net earnings-3.3477.35507.11269.76

Assets (kDKK)

2020
2021
2022
2023
Intangible assets total
Tangible assets total
Investments total
Long term receivables total
Inventories total
Current amounts owed by group member comp.882.96
Current other receivables131.597.66105.3124.55
Short term receivables total131.597.66105.31907.51
Cash and bank deposits287.40721.181 067.70313.11
Cash and cash equivalents287.40721.181 067.70313.11
Balance sheet total (assets)418.99728.841 173.011 220.63

Equity and liabilities (kDKK)

2020
2021
2022
2023
Share capital100.00100.00100.00100.00
Retained earnings-11.38495.72
Profit of the financial year-3.3477.35507.11269.76
Shareholders equity total96.66177.36595.72865.48
Non-current deferred tax liabilities61.46
Non-current liabilities total61.46
Current trade creditors1.110.72
Current owed to group member122.44436.57226.76
Short-term deferred tax liabilities229.15
Other non-interest bearing current liabilities199.89113.80120.67293.69
Current liabilities total322.33551.48577.29293.69
Balance sheet total (liabilities)418.99728.841 173.011 220.63
Try the full version of our system for free
Bankruptcy risk visualization example

... and more!

No registration needed.